Literature DB >> 2624472

IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.

G L Toms1, M S Webb, P D Milner, A D Milner, E G Routledge, R Scott, G M Stokes, A Swarbrick, C E Taylor.   

Abstract

Serum antibodies to the fusion (F) and large glycoprotein (G) of respiratory syncytial virus in the serum of 57 infected infants were measured by enzyme linked immunosorbent assay (ELISA). Most serum samples taken at the time of admission to hospital contained antibodies to both glycoproteins, and overall there was no significant evidence of a selective deficiency of antibody to either viral antigen. Less than a quarter of the infants showed rising IgG antibody titres to either glycoprotein after infection, whereas over threequarters produced an IgM response. There was a significant correlation between IgG response to viral glycoproteins and the age of the infant. The correlation of age with the IgM response was less pronounced, and there was no correlation between serum IgG antibody derived transplancentally in the acute phase of infection and IgM response to either glycoprotein. Neither IgG or IgM responses correlated with a clinical assessment of the severity of infection in the infants. IgM responses, however, were weakly correlated with reduced secretion of infectious virus in the upper respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2624472      PMCID: PMC1792918          DOI: 10.1136/adc.64.12.1661

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Respiratory syncytial virus infection of the newborn.

Authors:  G A Neligan; H Steiner; P S Gardner; J McQuillin
Journal:  Br Med J       Date:  1970-07-18

2.  Monoclonal antibodies protect against respiratory syncytial virus.

Authors:  G Taylor; E J Stott; M Bew; B F Fernie; P J Cote
Journal:  Lancet       Date:  1983-10-22       Impact factor: 79.321

3.  Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.

Authors:  K McIntosh; J McQuillin; P S Gardner
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  An enzyme-linked immunosorbent assay (ELISA) for IgG and IgA antibodies to respiratory syncytial virus in low dilutions of secretions of human serum and secretions.

Authors:  N Nandapalan; E Routledge; G L Toms
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

5.  Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection.

Authors:  F W Bruhn; A S Yeager
Journal:  Am J Dis Child       Date:  1977-02

6.  Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.

Authors:  K A Ward; P R Lambden; M M Ogilvie; P J Watt
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

7.  Detection by ELISA of IgA and IgM antibodies in secretion and IgM antibodies in serum in primary lower respiratory syncytial virus infection.

Authors:  A Hornsleth; B Friis; P C Grauballe; P A Krasilnikof
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

8.  Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.

Authors:  V G Hemming; W Rodriguez; H W Kim; C D Brandt; R H Parrott; B Burch; G A Prince; P A Baron; R J Fink; G Reaman
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  Maternal antibody and respiratory syncytial virus infection in infancy.

Authors:  M M Ogilvie; A S Vathenen; M Radford; J Codd; S Key
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

10.  Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.

Authors:  W P Glezen; A Paredes; J E Allison; L H Taber; A L Frank
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

View more
  5 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Severity of respiratory syncytial virus infections and immunoglobulin concentrations.

Authors:  W J Tissing; H A van Steensel-Moll; M Offringa
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 3.  Respiratory syncytial virus: virology, diagnosis, and vaccination.

Authors:  G L Toms
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.

Authors:  J Forster; O Maier; J Löbbert; K Kaufmehl; H J Streckert; H Werchau
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

5.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.